AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-15933368_ITM" title="Facts and information about FDA warns on cox-2 inhibitors, naproxen drug products.(Food and Drug Administration)(Brief article)">FDA warns on cox-2 inhibitors, naproxen drug products.(Food and Drug Administration)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Drug Store News are available.
Frequently asked questions about RSS feeds
FDA warns on cox-2 inhibitors, naproxen drug products.(Food and Drug Administration)(Brief article)
WASHINGTON -- The Food and Drug Administration announced that it is requiring evaluation of all prevention studies that involve the cox-2 selective agents Celebrex (celecoxib) and Bextra (valdecoxib) in light of the new evidence that these drugs may increase the risk heart attack and stroke.
The FDA issued the advisory because recently released data from controlled clinical trials …
Related articles from newspapers, magazines, journals, and more
-
- Two COX-2 inhibitors left after Vioxx withdrawal: CV events not linked to...
-
Magazine article from: Family Practice News
Mechcatie, Elizabeth Peck, Peggy
October 15, 2004
700+ words
-
- FDA's shift on painkillers leaves patients confused.
-
News wire article from: The Philadelphia Inquirer (Philadelphia, PA)
April 12, 2005
700+ words
